Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Sarepta Therapeutics
Company

Sarepta Therapeutics

Tracked across 1 events · 7 articles · First seen Mar 06, 2026 · Last active Mar 08, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Regulatory
Vinay Prasad Departs FDA, Boosting Drug Stocks
Sarepta Therapeutics was involved in contentious decisions during Vinay Prasad's tenure at the United States===Food and Drug Administration regarding its Duchenne muscular dystrophy gene therapy, Elevidys. The impact of Prasad's departure on Sarepta Therapeutics is not explicitly stated but could be inferred as potentially positive.
Mar 06, 2026 · 7 articles
NEWSDESK
Track Sarepta Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.